This inventor holds 1 USPTO granted patent and 9 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: University of Michigan. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Laurent Essioux: Innovator in Chronic Kidney Disease Biomarkers
Introduction
Laurent Essioux is a notable inventor based in Attenschwiller, France. He has made significant contributions to the field of chronic kidney disease (CKD) through his innovative research and patented technologies. His work focuses on identifying biomarkers that can predict the progression of CKD, which is crucial for improving patient outcomes.
Latest Patents
Laurent Essioux holds a patent for "Biomarkers and methods for progression prediction for chronic kidney disease." This invention involves the detection of levels of various biomarkers, including NTpro BNP, EGF, Apo H, GDF-15, and the albumin-to-creatinine ratio. These biomarkers are essential for assessing the risk of CKD progression and for monitoring the effectiveness of CKD therapies.
Career Highlights
Throughout his career, Laurent has worked with prestigious institutions, including the University of Michigan and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in kidney disease.
Collaborations
Laurent has collaborated with talented individuals such as Maria Bobadilla and Laura Badi. Their combined expertise has further advanced the understanding and treatment of chronic kidney disease.
Conclusion
Laurent Essioux's innovative work in the field of chronic kidney disease biomarkers highlights his commitment to improving patient care through scientific research. His contributions are paving the way for better monitoring and treatment options for those affected by CKD.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile